US Treasury Proposes New Investment Restrictions Targeting AI, Biotech, and Advanced Chip Funding to China
What Happened — The U.S. Treasury Department released a proposed rule expanding the Outbound Investment Security Program to tighten U.S. capital flows into China (and other high‑risk jurisdictions) for a set of “sensitive” technologies: advanced semiconductors, artificial‑intelligence systems, quantum computing, high‑performance computing, hypersonic systems, and biotechnology—including gene‑editing, immunotherapies, and brain‑computer‑interface research. The rule, issued under the Comprehensive Outbound Investment National Security Act, would require U.S. investors to report certain transactions and would prohibit others, pending a public‑comment period before final regulations are adopted.
Why It Matters for Trust & Control Assurance — The proposal tests an organization’s supply‑chain risk‑management and investment‑oversight controls; Verisq’s third‑party risk management capability can help map, monitor, and evidence compliance with the new reporting obligations.
Who Is Affected — Companies developing or financing AI models, biotech therapeutics, and advanced semiconductor technologies; investors, venture‑capital firms, and multinational R&D partners.
Recommended Actions —
- Inventory all outbound investments and partnerships that involve the listed technology categories.
- Map existing due‑diligence and reporting processes to the proposed thresholds; identify gaps.
- Begin collecting evidentiary artifacts (investment contracts, due‑diligence reports, board approvals) to demonstrate readiness for the forthcoming reporting regime.
Technical Notes — The rule does not reference a specific vulnerability; it is a policy instrument that expands the scope of “sensitive” technologies and adds biotechnology to the list of sectors subject to outbound‑investment scrutiny. Source: TechRepublic article